For best results, selecting an optimal CBD dosage depends on several variables such as your weight, body chemistry and the concentration of CBD found in products like capsules or gummies that feature expressed milligram contents – making determining an accurate dose easier.
Sahinovic et al.47 found that an acute dose of 300 mg oral CBD significantly reduced anxiety and cognitive impairment associated with recall of traumatizing events for patients suffering PTSD.
Dosage for anxiety
CBD is a non-psychoactive natural compound that can effectively decrease anxiety and relax the body, as well as lessen symptoms of depression and stress. Furthermore, CBD improves sleep quality as well as digestive issues associated with anxiety; additionally it boosts cognitive processing speeds and alleviates pain.
CBD may interact with certain medications, such as blood thinners and antiepileptics. Furthermore, it could impact a liver-related enzyme responsible for breaking down prescription medicines like acetaminophen; so it is wise to consult your physician prior to using CBD for anxiety relief.
Small amounts of CBD may provide immediate relief for anxiety symptoms; however, its full effect may take time to develop in others. Depending on your individual condition and goals, choose either fast-acting ingredients for sudden attacks or relaxing ones to ease tension throughout the day. CBD oil may also ease nausea and irritability symptoms. Look for products made with organic hemp that have been third-party tested for pesticides and heavy metals to ensure safe product usage.
Dosage for pain
CBD is a non-psychoactive cannabinoid that may help relieve chronic pain. Its anti-inflammatory properties reduce inflammation, helping with muscle spasticity associated with multiple sclerosis or cancer pain relief as well as treating anxiety and depression. CBD may be taken orally or as a tincture, capsule patch or vape; its effectiveness depends on factors like body weight and existing medications being taken for the condition being treated.
Recent research conducted via modified Delphi process surveyed international experts to develop expert guidance for clinicians regarding dosing medical cannabis (MC) for chronic pain patients. The authors proposed three protocols based on safety, tolerability, and effectiveness considerations; this research is an important step towards creating safe and effective guidelines for using medical cannabis; however placebo-controlled clinical trials must support them to complete this objective process.
Dosage for sleep
CBD may help improve the quality of sleep apnea sufferers. CBD can alleviate anxiety and pain associated with insomnia. Unfortunately, CBD cannot address underlying causes like airway blockages or structural problems; but it may help people fall asleep quickly when an episode arises.
Begin with a lower dose and gradually increase it over time. Your daily dosage of CBD depends on both your weight and what condition is being treated; generally speaking, an effective daily dose could range anywhere between 25 mg and 100 mg of CBD.
CBD may help with your sleep problems when taken either before bed or throughout the day. For maximum effectiveness, look for products containing other cannabinoids and terpenes in addition to CBD for maximum results. However, remember that CBD doesn’t act like sleeping pills in terms of instantaneously knocking you out.
Dosage for seizures
CBD can be an effective treatment option for seizures in those suffering from Dravet and Lennox-Gastaut syndromes, and as an add-on therapy with other anti-seizure drugs. Starting dosage should begin at 2.5 mg/kg twice daily with dosage adjusted based on individual response; it’s advised that seizure frequency be monitored prior to beginning this therapy and consultation should take place with a neurologist first.
This open-label study is intended to evaluate the safety and efficacy of cannabis-derived cannabidiol (CBD) for treating TRE. Participants were assessed at baseline, 12 weeks, 24 weeks and 48 weeks; demographic and AEP/CSSS/SF data was gathered using standard forms and questionnaires at each assessment point.
Epidiolex’s randomized controlled trial of CBD showed it could significantly decrease seizures among people living with tuberous sclerosis complex (TSC), an incurable disorder that causes noncancerous tumors to grow throughout their bodies. A dose of 20 mg/kg/day reduced seizures for 48% of participants while improving quality of life for 55%.
